Injectable Targets Décolleté Wrinkles
New indication expands use of injectable biostimulator beyond the face.
-
By
-
Kathryn Wighton
-
April 10, 2026
-
Clinical Scorecard: Injectable Targets Décolleté Wrinkles
At a Glance
| Category | Detail |
| Condition | Wrinkles in the décolleté area |
| Key Mechanisms | Biostimulation promoting collagen, elastin, and structural protein production |
| Target Population | Patients aged 22 years and older |
| Care Setting | Cosmetic dermatology and aesthetic treatment settings |
Key Highlights
- RADIESSE dermal filler approved by FDA for décolleté wrinkle treatment in patients 22+ years
- Effects last up to 2 years by enhancing dermal integrity through collagen and elastin production
- High patient satisfaction with over 80% reporting improved skin tightness and interest in repeat treatments
Guideline-Based Recommendations
Diagnosis
- Assessment of wrinkles and skin laxity in the décolleté area suitable for injectable treatment
Management
- Use RADIESSE dermal filler as a biostimulator to improve skin firmness and smoothness
- Avoid use in patients with allergies to product components, severe allergic reaction history, or bleeding disorders
- Do not use in anatomical areas where safety is not established, such as lips and periorbital region
Monitoring & Follow-up
- Monitor for adverse events including bruising, redness, swelling, pain, itching, difficulty chewing, and nodules
- Be vigilant for signs of unintentional intravascular injection which may cause vision abnormalities or stroke
Risks
- Potential adverse events at injection site including bruising and nodules
- Serious complications from intravascular injection such as vision abnormalities and stroke
- Contraindicated in pregnant or breastfeeding patients and those under 22 years for décolleté indication
Patient & Prescribing Data
Patients aged 22 years and older seeking treatment for décolleté wrinkles
More than 80% patient satisfaction with skin tightness; 83% likely to repeat treatment after 1 year; 93% interested in additional treatments
Clinical Best Practices
- Confirm patient eligibility including age and absence of contraindications before treatment
- Educate patients on expected outcomes and potential adverse events
- Use proper injection techniques to minimize risk of intravascular injection
- Schedule follow-up to assess treatment efficacy and monitor for adverse effects
References